• News
  • SAN DIEGO
  • Finance

Dexcom gains FDA approval; stocks rise

Share prices in San Diego's Dexcom Inc. rose nearly 6 percent in after-hours trading Tuesday after the company announced it had received FDA approval for a new system aimed at providing diabetic patients and their doctors with real-time information about their sugar levels.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Dexcom Inc.

Company Website

5555 Oberlin Drive
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
DXCM
61.98
  1.82  
+ 3.03%
665,777,000
64.64
28.09

Insider Trade Data

Date Insider Shares Type Value
03/25/2015 Balo, Andrew K 7,500 Sell $457,849
03/25/2015 Balo, Andrew K 7,500 Exchange $73,500
03/23/2015 Doubleday, Richard B 4,000 Sell $244,992
03/23/2015 Doubleday, Richard B 4,000 Exchange $24,120
03/23/2015 Pacelli, Steven Robert 14,000 Sell $858,680

Dexcom Inc. Executive(s):

Terrance Gregg

  • Chief Executive Officer, Director

Kevin Sayer

  • Director, President

Patrick Murphy

  • Assist. General Counsel

Similar Companies

NAICS - -
Subscribe Today!